Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: PTSC no longer covered by Reuters
Reply New Message
Back To Forum List View
PTSC no longer covered by Reuters

Cautious
Nov 25, 2008 07:28AM
Re: PTSC no longer covered by Reuters
2
cantwait
Nov 25, 2008 07:40AM

Re: casntwait, "found it very peculiar that Reuters was covering a penny stock like that, AND listing it as outperform"

I agree.

And they needed to drop PTSC because it was having a negative impact on their analyst's measurement stats - noted below.

"over the long term, stocks rated Outperform (30% of all stocks they rate) will, in the aggregate, outperform stocks rated Neutral (40% of all stocks they rate), and that stocks rated Neutral will, in the aggregate, outperform stocks rated Underperform (30%)"



Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply